PER percheron therapeutics limited

Ann: Webinar Presentation - Phase IIb study of avicursen, page-29

  1. 3,531 Posts.
    lightbulb Created with Sketch. 680
    As mentioned I believe voit and clarys explanation - too hard for a tiny aussie speccy to afford. Could it have saved us, maybe! Should it have been included in hindsight, yes! Are the BOD responsible... they know science better than us x 100, so likely, yes! But I dont know enough about science to point the finger so convincingly. As mentioned Im still unsure as to the professionalism of the ph2a and the mri attached to that. But lets assume the ph2a mri was correct (even tho the pul proved to be unaligned w 2b). If the mri together with cd49d stuff showed drug efficacy, and was accepted by fda, my non scientific guess would say 'the drug worked'. But, how well is the question, as CAP and DUVY had their statistically meaningful puls to compete with... with a primary endpoint of pul inline w placebo we'd prob be in very rough waters, but perhaps not on this coral reef.

    Hindsight is a glorious thing.
    Last edited by RYNZN: 07/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $5.737K 573.7K

Buyers (Bids)

No. Vol. Price($)
1 3633138 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3174000 4
View Market Depth
Last trade - 15.22pm 17/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.